Serum Human epididymal protein 4 as a predictor of adverse events in acute ischemic stroke patients receiving antiplatelet therapy

Na Liu, Ning Bao, Guang Liu, Xiaowei Luo · 2026

Read Serum Human epididymal protein 4 as a predictor of adverse events in acute ischemic stroke patients receiving antiplatelet therapy by Na Liu, Ning Bao, Guang Liu, Xiaowei Luo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13474719.txt.

Description

Liu and co-authors measured HE4, a protein better known as an ovarian cancer and kidney injury marker, in 144 patients admitted with acute ischemic stroke and treated with antiplatelet drugs. Their 2026 cohort study asked whether admission blood levels forecast cardiovascular events or another stroke.

Stroke patients carried far more HE4 than healthy controls, averaging 116.4 picomoles per liter against 25.3 in the comparison group. Adjusted survival models made the marker a strong independent predictor: elevated HE4 carried a hazard ratio of 3.02 for cardiovascular events and 3.81 for stroke recurrence on the fitted models, each clearly significant. The authors suggest the kidney-fibrosis signal captures vascular fragility that standard stroke workups miss, while cautioning that coexisting cancers could distort the test.

Catalog record

CREATORNa Liu, Ning Bao, Guang Liu, Xiaowei Luo
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE22 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13474719

Browse the full library · About the Tower of Babel